Platinum-resistant Epithelial Ovarian Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-01-07
Clinical Trial Update: A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BAT8006 for platinum-resistant epithelial ovarian cancer, fallopian tube cancer, and primary peritonea…